ABCL
Price
$2.06
Change
+$0.03 (+1.48%)
Updated
May 12 closing price
Capitalization
605.92M
91 days until earnings call
ABSI
Price
$2.93
Change
+$0.18 (+6.55%)
Updated
May 12 closing price
Capitalization
350.76M
Earnings call today
Ad is loading...

ABCL vs ABSI

Header iconABCL vs ABSI Comparison
Open Charts ABCL vs ABSIBanner chart's image
AbCellera Biologics
Price$2.06
Change+$0.03 (+1.48%)
Volume$4.4M
Capitalization605.92M
Absci
Price$2.93
Change+$0.18 (+6.55%)
Volume$3.06M
Capitalization350.76M
ABCL vs ABSI Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ABSI commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ABSI is a Hold.

Ad is loading...
COMPARISON
Comparison
May 13, 2025
Stock price -- (ABCL: $2.06 vs. ABSI: $2.93)
Brand notoriety: ABCL and ABSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 109% vs. ABSI: 98%
Market capitalization -- ABCL: $605.92M vs. ABSI: $350.76M
ABCL [@Biotechnology] is valued at $605.92M. ABSI’s [@Biotechnology] market capitalization is $350.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileABSI’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ABSI’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and ABSI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ABSI’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • ABSI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ABCL and ABSI are a bad buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а -5.94% price change this week, while ABSI (@Biotechnology) price change was +2.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.48%. For the same industry, the average monthly price growth was +10.12%, and the average quarterly price growth was -9.68%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

ABSI is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (-3.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($606M) has a higher market cap than ABSI($351M). ABSI YTD gains are higher at: 11.832 vs. ABCL (-29.693). ABSI has higher annual earnings (EBITDA): -83.27M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. ABSI (127M). ABSI has less debt than ABCL: ABSI (12M) vs ABCL (67.8M). ABCL has higher revenues than ABSI: ABCL (23.1M) vs ABSI (4.21M).
ABCLABSIABCL / ABSI
Capitalization606M351M173%
EBITDA-211.2M-83.27M254%
Gain YTD-29.69311.832-251%
P/E RatioN/AN/A-
Revenue23.1M4.21M549%
Total Cash605M127M476%
Total Debt67.8M12M565%
TECHNICAL ANALYSIS
Technical Analysis
ABCLABSI
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 6 days ago
89%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHTX28.66N/A
N/A
Nationwide Bailard Tech & Sci R6
AIEAX16.89N/A
N/A
American Beacon International Eq A
LGLCX37.18N/A
N/A
Lord Abbett Growth Leaders C
MXVHX6.56N/A
N/A
Empower Large Cap Value Instl
GDLFX18.20N/A
N/A
Gotham Defensive Long 500 Institutional

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.48%
CRSP - ABCL
62%
Loosely correlated
+5.53%
ABSI - ABCL
59%
Loosely correlated
+6.55%
RXRX - ABCL
58%
Loosely correlated
+7.16%
NTLA - ABCL
58%
Loosely correlated
+5.30%
BEAM - ABCL
57%
Loosely correlated
+4.77%
More

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+6.55%
RXRX - ABSI
60%
Loosely correlated
+7.16%
CRSP - ABSI
59%
Loosely correlated
+5.53%
ABCL - ABSI
59%
Loosely correlated
+1.48%
BEAM - ABSI
57%
Loosely correlated
+4.77%
NTLA - ABSI
51%
Loosely correlated
+5.30%
More